Last reviewed · How we verify

NCT07028177

Changes in Etomidate Dosage in Insomnia Patients Undergoing Digestive Endoscopy

Recruiting now Last updated 10 September 2025
What this trial tests

trial testing No interventions, it is a observational study in Insomnia in 840 participants. Currently enrolling.

Timeline
12 June 2025
Primary endpoint
31 March 2027
31 March 2027

Quick facts

Lead sponsorBeijing Tiantan Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment840
Start date12 June 2025
Primary completion31 March 2027
Estimated completion31 March 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 64, any sex, with Insomnia or Digestive Endoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the dosage requirement of etomidate during digestive endoscopy between patients with insomnia and those with normal sleep pattern.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No interventions, it is a observational study

Trials testing the same drug.

Other recruiting trials for Insomnia

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07028177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing